Here are relevant reports on : performance-testing-market
-
Q-TOF Mass Spectrometry Market by Application (Biotech Applications, Pharmaceutical Applications, Food & Beverage Testing, Environmental Testing, Petrochemical Applications), and Region (North America, Europe, APAC, and Row) & Geography
The global Q-TOF mass spectrometry market is expected to grow at a CAGR of 7.7%. The growth of this market is majorly driven by the technological advancements pertaining to Q-TOF mass spectrometry technology, government initiatives for pollution control and environmental testing, high expenditure on R&D activities of mass spectrometry supplements in pharmaceutical and biotechnological applications, stringent government regulations regarding drug safety, and increased focus on producing high-quality food. However, the high costs of Q-TOF instruments is restraining the growth of the Q-TOF mass spectrometry market. Waters Corporation (US), Agilent Technologies (US), and SCIEX (Subsidiary of Danaher) (US) are the key players in the Q-TOF mass spectrometry market. Other players involved in this market are Bruker (US) and Shimadzu Corporation (Japan).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Atomic Spectroscopy Market by Technology (Atomic Absorption Spectroscopy/X-Ray Fluorescence/X-Ray Diffraction/ICP-MS/ICP-OES) & by Application (Food & Beverage Testing/Pharmaceuticals & Biotechnology / Environmental Testing) - Analysis & Global Forecast to 2020
The atomic spectroscopy market is poised to reach USD 5.60 Billion by 2020, growing at a CAGR of 6.0% during the forecast period of 2015 to 2020. The growth of the overall atomic spectroscopy market can be contributed to rising investments, funds, and grants by government bodies worldwide and technological advancements. In addition, growing food safety concerns and stringent regulations have contributed to market growth.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Microbiology Testing Market by Product [Instrument, Reagent & Kit, Consumable], Technology [Traditional (Manual Counting, Culture), Rapid (Nucleic Acid, Viability)], End User [Pharma, Biotech, Food, Water, Environmental Testing]-Global Forecast to 2031
The global microbiology testing market, valued at USD 7.45 billion in 2025, stood at USD 7.79 billion in 2026 and is projected to advance at a resilient CAGR of 5.3% from 2026 to 2031, culminating in a forecasted valuation of USD10.09 billion by the end of the period. The major factors driving the growth of the market include the rising need for contamination control, rising government regulations in various sectors and continuous innovation in microbiology testing.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs) & Region - Global Forecast to 2025
The global mycoplasma testing market growth is primed to transition from $689 million in 2020 to $1,095 million by 2025, showcasing a strong CAGR of 9.7%. The global market's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact on Food Safety Testing Market by Testing Technologies (DNA-based, Immunoassay-based, Chromatography- & Spectroscopy-based), Targets Tested (Pathogen, GMO, Allergen, and Mycotoxin), and Region - Global Forecast to 2021
The COVID-19 impact on food safety testing market is expected to grow from USD 10.5 billion in 2020 to USD 13.3 billion by 2021 at a compound annual growth rate (CAGR) of 21.4% during the forecast period.The key players in this market include Eurofins (Luxembourg), SGS (Switzerland), Intertek (UK), Bureau Veritas (France), and TUV SUD (Germany). Eurofins (Luxembourg) is an international group of laboratories that provide testing and support services to the food industries as well as to governments.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Zika Virus Testing Market by Technology, (Molecular Test (Polymerase Chain Reaction, Nucleic Acid Amplification Testing), Serology Test (Elisa, Prnt), End User (Diagnostic Laboratory, Hospital, Clinics, Academic Institutes) - Global Forecast to 2023
The Zika virus is a mosquito-borne flavivirus that was initially discovered in Uganda’s Zika forest in 1947. Before 2015, outbreaks of Zika virus infection had been restricted to some parts of Africa, Asia, and the South Pacific. In early 2015, a widespread outbreak of Zika fever, caused by the Zika virus detected in Brazil and subsequently spread to other parts of South and North America. Due to this, a number of countries issued travel warnings, and the outbreak will result in restricts tourism significantly. Furthermore, the outbreak raised concerns regarding the safety of athletes and viewers at the 2016 Summer Olympics in Rio de Janeiro. This sudden outbreaks resulted in increased demand for Zika virus testing.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Drug Screening Market by Offering [On-site Testing, Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)], Sample (Blood, Urine, Hair), Drug (Cannabis, Alcohol), End User (Workplace, Law, Hospitals) - Global Forecast to 2030
The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period. The market for drug screening is being fueled by growing workplace and clinical testing programs, an increased need for opioid/polysubstance monitoring, and an increased use of rapid point-of-care technologies and advanced confirmatory testing (LC MS/MS) systems.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Composites Testing Market by Testing Type (Destructive, Non-Destructive), Product Type (Continuous Fiber, Discontinuous Fiber, Polymer Matrix, Ceramic Matrix), Application (Aerospace & Defense, Transportation, Wind) & Region - Global Forecast to 2026
The composites testing market was valued at USD 1.47 Billion in 2015, and is projected to reach USD 3.06 Billion in 2026 at a CAGR of 6.95%. The use of composites is becoming crucial in the interior and exterior structural applications of aircraft and transport vehicles due their high strength, and superior performance. These composites have to comply with the stringent composites testing standards and manufacturers’ proprietary testing standards to ensure safety and durability.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Medical Device Testing Market by Service (Testing, Inspection, Certification), Sourcing (In-house, Outsourced), Technology (Active Implant, Active, Non-active, IVD, Ophthalmic, Orthopedic & Dental, Vascular), Class (I, II, III) – Global Forecast to 2028
The global medical device testing market is expected to grow from USD 10.6 billion in 2023 to USD 13.5 billion by 2028, at a compound annual growth rate (CAGR) of 4.9% during the forecast period.The Key players Eurofins Scientific (Luxembourg), Intertek Group plc (UK), SGS Société Générale de Surveillance SA. (Switzerland), Bureau Veritas (France), TÜV SÜD (Germany).
- Published: October 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
